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Summary: In an in-vitro simulation of an intravascular cannula enclosed in 
a fibrin sheath, 0.03 mg 1-i of mupirocin prevented significant colonization 
[ > 15 colony forming units (cfu)] by two clinical isolates of Staphylococcus 
epidermidis and one each of S. saprophyticus, S. hominis and S. haemolyticus. 
This suggests that in vivo, where protein binding of mupirocin is 95597%, 
1 mg 1-l of mupirocin at the cannula surface would be required to prevent 
colonization. 
These results support the findings of our previously published prospective 
controlled trial, in which mupirocin applied to the insertion sites of 172 
internal jugular cannulae reduced the rate of colonization of cannula tips to 
5%, compared with 25% for the 186 controls (P<O.OOl). Of the 46 colonized 
cannula tips from 110 control patients, the same species was isolated from the 
skin of the insertion site in 67% and from the lumen flush in only 1.5%. 
Analysed by patient, mupirocin reduced the proportion of patients with 
colonized tips from 17% to 3% after 24 h of infection, and from 35 to 10% 
after 48 h (P=O.O02). The use of agar containing charcoal, as a mupirocin 
neutralizer, and the incubation of tip-culture plates flooded with the Oxford 
staphylococcus, gave no evidence of carry over of mupirocin onto cannulae 
removed from mupirocin-treated patients. 
Keywords: Intravenous cannulae; colonization; mupirocin; iodine; staphylo- 
cocci. 
Introduction 
The proportion of central venous cannulae that give rise to septicaemia has 
been reported as 3.8-21 %.le5 Although there is controversy as to whether 
the skin or the cannula hub is the source of organisms,6 several studies have 
confirmed a correlation between organisms cultured from the skin of the 
insertion site and those subsequently isolated from the cannula tip.‘-12 
Suppression of skin flora at the insertion site is therefore essential, and 
Maki13 has recommended disinfection of the skin with tincture of iodine. In 
a placebo-controlled trial we recently showed that local application of 
mupirocin to the site of insertion of internal jugular cannulae markedly 
reduces colonization of the cannula tip, al4 these results are reviewed here 
with some new supporting in-vitro data. 
0195-6701/91/09BO47+ 11 603.00/O 
47 
0 1991 The Hosptal Infection Society 
48 R. L. R. Hill and M. W. Casewell 
Materials and methods 
In-vitro simulation 
In vivo, the intravascular segment of the percutaneously inserted cannula 
becomes surrounded by a fibrin sheath which connects to the subcutaneous 
tract. l5 In addition, it is thought that organisms from the skin at the 
insertion site enter the subcutaneous tract and reach the cannula tip by 
capillary action. l6 The in-vitro arrangement shown in Figure 1 simulates 
the effect of mupirocin on the colonization of the cannula tip in the closed 
environment of a fibrin sheath. The procedure used was as follows: 
(1) Doubling dilutions of mupirocin from 19-0~004 mg 1-l were made in 
10 ml aliquots of Iso-sensitest broth (Unipath CM473) contained in 30 ml 
glass universal containers. 
(2) 25 mm segments of 16 gauge ‘Abbocath T’ (Abbott Laboratories) 
cannulae were immersed in broth with (test), or without (control), 
mupirocin. 
(3) For each experiment, test and control broths were inoculated with 
dilutions of overnight broth cultures of one of five test strains of 
coagulase-negative staphylococci. We used two clinical isolates of S. 
epidermidis (MICs 0.06 and 0.025 mg l-i), and one each of S. saprophyticus 
(MIC 0.03 mg l-l), S. hominis (MIC 0.12 mg 1-l) and S. haemolyticus (MIC 
0.03 mg 1-l). The final inoculum was approximately lo* cfu ml-‘. 
(4) After incubation at 37°C for 18 h, cannula segments were removed 
from their broths and drained for 3 min on sterile filter paper. 
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Figure 1. The in-vitro simulation. 
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(5) Segments were then rolled back and forth five times on blood agar 
according to the method of Maki et ~1.‘~ 
Controlled trial of mupirocin for the reduction of colonization of internal 
jugular cannulae 
In a prospective study reported previously in this Journal, I4 218 
cardiothoracic patients were randomized to receive skin preparation of the 
insertion site of ‘Abbocath T’ cannulae (inserted into the internal jugular 
vein) with tincture of iodine (108 controls) or tincture of iodine followed by 
application of sterile 2% calcium mupirocin ointment (110 test patients). 
Routine peri-operative chemoprophylaxis consisted of 80 mg of gentamicin 
plus 500 mg of flucloxacillin or 500 mg of erythromycin for 48 h. Cannulae 
were removed postoperatively, usually within 48 h of the operation, by a 
research control of infection nurse. At redressing and cannula removal, 
insertion sites were assessed for signs of local infection. 
Before cannula removal, all traces of antibiotic ointment and iodine were 
removed from the insertion site. The skin was sampled for culture and then 
cleaned with an alcohol-impregnated swab. After removal of the cannula, 
5 ml of broth was flushed through the lumen and sent with the cannula to 
the laboratory. The detailed microbiological methods have been described 
elsewhere” and included semiquantitative culture of the tip and 
intracutaneous segments on blood agar according to the method of Maki et 
~1.‘~ followed by enrichment cultures. The lumen flush was also cultured 
directly and by enrichment. The possibility of carry-over of mupirocin on 
to the removed cannulae was assessed by three methods during weeks 3-6 
and 346 of the 37-week trial: firstly, by culture of 120 colonized cannula 
tips on blood agar with, and without, a neutralizer, namely 2% charcoal 
(Oxoid L9); 66 of these tips were from patients in the mupirocin group. 
Secondly, 120 skin swabs were also cultured on charcoal blood agar, 66 of 
which were from mupirocin-treated skin. Lastly, 0.5 ml of an overnight 
broth culture of mupirocin-sensitive Oxford staphylococcus, diluted to give 
a semi-confluent growth (see Hill et &.,‘4r18) was pipetted onto 120 
incubated tip culture plates which were then re-incubated for 18 h and 
re-examined for zones of inhibition which, if present, might suggest the 
presence of mupirocin carried over at the time of inoculation with the 
cannula tip. 
Results 
In-vitro simulation 
Cannula segments that had been immersed in control broths, without added 
mupirocin, yielded confluent growth from the rolled cannula segment. 
Figure 2 shows the influence of various concentrations of mupirocin on the 
recovery of each of the five test strains of coagulase-negative staphylococci 
from the cannula segments. At concentrations of 0.06 mg l-‘, none of the 
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Figure 2. Colony counts from roll plates of cannulae exposed for 18 h to increasing 
concentrations of mupirocin. 
five strains were recovered after 18 h incubation with the cannulae. As the 
concentration of mupirocin decreased so the number of recoverable cfus for 
each strain increased. A concentration of O-03 mg I-’ of mupirocin was also 
adequate to prevent significant colonization of the cannula segments (i.e. 
< 15 cfus). However, at 0.015 mg l-‘, 10 cfus of S. hominis and 220 cfus of 
strain B of S. epidermidis were recovered. In general, these differences 
seemed to correlate with the MIC of each organism: strain B of S. 
epidermidis had the highest MIC (O-025 mg 1-l) and the highest number of 
cfus recovered at each concentration of mupirocin, whereas S. 
suprophyticus, which had an MIC of O-03 mg l-‘, yielded the lowest number 
of recoverable cfus. However, there were some strain differences which did 
not follow the MIC. For example, strain A of S. epidermidis, which had an 
MIC of O-06 mg l-‘, yielded fewer cfus when exposed to 0*004mg 1-l of 
mupirocin than did the S. haemolyticus which had a lower MIC of 
0.03 mg 1-l. 
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Controlled trial 
The results of this trial have been reported elsewhere’4v’8 and the main 
findings will be summarized here along with some previously unpublished 
data. The influence of mupirocin on the main source of organisms for the 
colonization of cannula tips will be further considered. 
There were 108 patients in the control group and 110 in the mupirocin 
group (test), from whom 186 and 172 cannulae, respectively, were obtained. 
The features of patients and cannulae in test and control groups were evenly 
matched. l4 Mupirocin e r duced the proportion of patients with significantly 
colonized cannula tips (i.e. recovery of > 15 cfus) regardless of in-situ time 
(Table I). Within 24 h of insertion, 17% of control patients had colonized 
tips, compared with 3% of the test patients who had mupirocin applied to 
the insertion site. Table I also shows that the proportion of patients with 
colonized cannulae increased with in-situ time. By 48 h, 35% of control 
patients had colonized tips, and this increased to 66% for patients with 
cannulae in situ for 48-120 h. This increase with time was less marked for 
mupirocin-treated patients, of whom only 10% had colonized lines in situ 
for up to 48 h. For the 17 test patients whose cannulae were in situ for 
48-120 h, none yielded > 15 cfu from their cannula tips. 
Analysis by cannulae (Table II) also showed that mupirocin reduced 
cannula colonization, regardless of in-situ time. In the control group, the 
intracutaneous segments were more often colonized than the tips: 32 (45%) 
vs 24 (34%), respectively for cannulae in situ for > 24-48 h. However, in the 
mupirocin group, the colonization rates of tips and intracutaneous segments 
were similar: 10% OS 12% for tips and intracutaneous segments, 
respectively, for in-situ times of > 24-48 h. Only 6(1*7%) of lumen flush 
cultures were positive, three in the test and three in the control groups. 
The results for the 358 cannulae obtained from 218 patients are shown in 
Table III. Overall, mupirocin reduced the proportion of colonized tips 
from 25% to 5% (PC 0.001). Even by enrichment culture of any segment 
there were fewer cannulae yielding growth in the mupirocin group (23%) 
compared with controls (64%) (P<O*OOl). There was no significant 
difference in the incidence of erythema or pus at the 183 puncture sites in 
the control group or in the 164 sites in the mupirocin group that were 
assessed for signs of local infection. 
Table I. Patients with one or more significantly colonized can&a tips 
Control patients 
In-situ time No. No. (X) with 
04 positive tip 
Mupirocin patients 
No. No (%) with 
positive tip 
Significance 
m 
<24 16 (17) 95 3 (3) 0.002 
24-<48 24 (35) 50 5 (10) 0.002 
48-120 9 6 (66) 17 0 < 0.001 
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Table II. Significant colonization of cannula segments according to in-situ time 
Cannula 
segment 
Control group Mupirocin group 
In-situ No. of % No. of % P value 
time (h) cannulae positive cannulae positive 
Tip <24 105 :: 103 3 < 0.001 
24--<48 71 10 < 0.025 
48-l 20 10 60 
:t 
0 <OGOl 
Intracutaneous <24 105 23 103 5 < 0.001 
24<48 71 45 50 
48-l 20 10 70 19 
ii < 041 
< 0.025 
Lumen flush <24 105 1 103 1 NS* 
24--c48 71 1 50 
48-l 20 10 1 19 
; E* * 
*NS = Not significant. 
Table III. Outcome for 186 control cannulae and 172 that were mupirocin-treated 
> 15 cfu from tip 
Any segment + ve by enrichment 
Associated with local signs 
No. of cannulae (%) 
Significance 
Controls Mupirocin m 
46 (25) 8( 5) < 0.001 
119 (64) 39 (23) < 0.001 
27 (15) 32 (20) NS* 
* IUS = Not significant. 
Coagulase-negative staphylococci were the most frequent isolates, 
accounting for 62% of isolates from the control group and 19% of those 
from the test group. Micrococci and corynebacteria each accounted for 8% 
of isolates from control cannulae and 5% from the test group. 
Staphylococcus aureus accounted for only 2% of isolates in the mupirocin 
group and 2% in the control group, whilst other organisms including the 
Enterobacteriaceae comprised 0.53.0%. For 31 (67%) of colonized cannula 
tips from control patients, the same species was also isolated from the skin 
of the insertion site. Only seven colonized cannulae (15%) yielded 
organisms that were also found in the lumen flush. For the test group the 
skin was identified as the source of organisms for only two cannulae. Both of 
these isolates were mupirocin resistant S. epidermidis that were isolated 
from the skin before treatment with mupirocin. For mupirocin-treated 
patients there was only one cannula for which the tip isolate could be found 
in the lumen flush. 
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Table IV. Influence of media on the rate of detection of significant colonization of can&a tips 
Control Mupirocin 
(N= 54) (N= 66) 
Number of significantly colonized tips with 
greater growth on media containing: 
Blood 
Blood + charcoal 
13 5 
2 0 
Table IV shows that, of 120 cannulae, none yielded significant counts 
( > 15 cfu) on charcoal blood agar alone. One significantly colonized tip was 
detected only on blood agar. None of the 120 skin swabs were positive on 
the charcoal whilst negative on blood agar but two were positive only on 
blood agar. When flooded with the Oxford staphylococcus, none of the 
cannula tip plates gave inhibition zones to suggest carry over of mupirocin. 
Discussion 
Our results show clearly that mupirocin can prevent colonization of central 
venous cannulae. In-vitro models have previously been used to investigate 
the influence of antimicrobial substances on the colonization of 
intravascular cannulae, 19-23 but our in-vitro experiments mimic more 
closely the static environment of an intravascular cannula enclosed by a 
fibrin sleeve that is seeded from skin-derived organisms.‘5~24’25 In &JO, skin 
organisms may gain access to the cannula tip by capillary action.” 
In our model, sub-inhibitory concentrations of mupirocin prevented 
significant colonization of central-venous cannula segments by five distinct 
strains of coagulase-negative staphylococci. This reduction of cannula 
colonization by sub-inhibitory concentrations has also been described for 
ciprofloxacin and fusidic acid.23 Sub-inhibitory concentrations of certain 
antibiotics are known to prevent bacterial adhesion,26 a prerequisite 
for colonization. Nevertheless, despite the possibility of beneficial 
sub-inhibitory effects, mupirocin did not prevent colonization of internal 
jugular cannulae by high-level mupirocin-resistant staphylococci derived 
from the insertion site in viva. The effect of sub-inhibitory concentrations 
on more resistant organisms, and the effect of longer exposure times, 
warrants further investigation. 
Microorganisms adhere to implanted surfaces via plasma-derived 
proteins which, for example, would be deposited on the surface of 
intravenous cannulae in viz~o.*~-~~ Because mupirocin is 95-97% 
protein-bound (Hill & Casewell, unpublished observations) c. 1 *O mg 1-l 
will be required to yield 0.03 mg 1-l of free mupirocin-the concentration 
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shown in this study that is required to prevent significant colonization with 
sensitive staphylococci. Determination of the half-life of mupirocin 
ointment at the cannula insertion site would give an indication of the 
maximum interval before re-application of the ointment that would ensure 
continuous delivery of adequate concentations of mupirocin, i.e. 
>l*Omgl-‘. 
In our controlled trial, we applied ointment containing 2% calcium 
mupirocin (20 000 mg I-‘) directly to the puncture site in anticipation that 
sufficient mupirocin would diffuse down the subcutaneous tract to prevent 
colonization of the cannula tip. It was also envisaged that the addition of 
mupirocin would suppress any regrowth of skin flora. As skin disinfection 
has been shown to influence contamination of the cannula lumen,’ 
percutaneous insertion of the cannula through mupirocin might also 
decrease luminal contamination. 
The results of the trial showed clearly that the application of mupirocin to 
the skin of the cannulation site after skin disinfection with tincture of iodine 
reduced significant colonization of cannulae inserted into the internal 
jugular vein from 25% to 5% (P<O*O01).‘4~‘8 For the test and control 
groups, both patients and cannulae were well matched. Previous studies on 
topical antibiotic ointments have usually investigated more heterogeneous 
groups of patients and indicated that local application of antibiotic ointment 
confers little, if any, benefit31-33 and may only be ‘suitable’ for peripheral 
lines.34 Although the majority of the patients studied were cannulated for 
< 48 h and were at low risk of acquiring a cannula-related bacteraemia, it is 
generally agreed that colonization is a prerequisite for bacteraemia and 
clinical cannula-related sepsis. 35,36 The longer a colonized line is left in situ 
the greater the correlation of positive semi-quantitative cannula cultures 
with bacteraemia.37*38 In our study, mupirocin significantly reduced the 
proportion of patients with one or more colonized cannula tips regardless of 
in-situ time. 
We took care to avoid carry over of ointment or iodine, at cannula 
removal. The use of agar containing charcoal, which served as a 
neutralizer39 did not improve the positivity rate of tip or skin cultures, and 
its use was thus discontinued. Indeed, charcoal agar often reduced bacterial 
growth, possibly by indiscriminant absorption of nutrients. Inoculation of a 
mupirocin-sensitive staphylococcus on to tip culture plates after incubation 
also failed to reveal evidence of antibiotic carry-over. 
The application of mupirocin to the insertion site did not result in the 
isolation of mupirocin-resistant organisms such as Pseudomonas or Candida 
spp. The isolates from cannula tips corresponded most often to those 
cultured from the skin at the insertion site, rather than to the infrequent 
isolates from the cannula lumen. Mupirocin greatly reduced the skin flora 
with a corresponding decrease in the number of colonized tips. This 
supports the view that the skin of the insertion site, rather than the lumen, is 
the main source of organisms for colonization of the tip.7-12 However, we 
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recognize that the junction between the cannula hub and the giving-set may 
assume importance with frequent make-and-break connections, for 
example during parenteral nutrition4M2 and haemodialysis.43 
We conclude that application of mupirocin to the insertion site reduces 
the colonization of internal jugular cannulae by sensitive staphylococci. In 
addition, we suggest mupirocin has marked potential for the reduction of 
cannula-related sepsis caused by staphylococci in high-risk patients. 
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